标题
Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
作者
关键词
-
出版物
PLoS One
Volume 13, Issue 10, Pages e0205018
出版商
Public Library of Science (PLoS)
发表日期
2018-10-10
DOI
10.1371/journal.pone.0205018
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors
- (2018) Raffaella Cincinelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Safe approaches for camptothecin delivery: Structural analogues and nanomedicines
- (2017) Pablo Botella et al. JOURNAL OF CONTROLLED RELEASE
- Small hybrid heteroaromatics: resourceful biological tools in cancer research
- (2017) Vikrant Abbot et al. RSC Advances
- Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach
- (2017) Kai-Cheng Hsu et al. Scientific Reports
- Panobinostat induces apoptosis via production of reactive oxygen species and synergizes with topoisomerase inhibitors in cervical cancer cells
- (2016) Lubna Wasim et al. BIOMEDICINE & PHARMACOTHERAPY
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An overview of molecular hybrids in drug discovery
- (2016) Gervais Bérubé Expert Opinion on Drug Discovery
- Histone deacetylase inhibitors in hematological malignancies and solid tumors
- (2015) Pusoon Chun ARCHIVES OF PHARMACAL RESEARCH
- Perspectives in the development of hybrid bifunctional antitumour agents
- (2015) Loana Musso et al. BIOCHEMICAL PHARMACOLOGY
- Senescence from G2 arrest, revisited
- (2015) Véronique Gire et al. CELL CYCLE
- Perspectives on Biologically Active Camptothecin Derivatives
- (2015) Ying-Qian Liu et al. MEDICINAL RESEARCH REVIEWS
- Current status of CPT and its analogues in the treatment of malignancies
- (2015) Guohua Hu et al. PHYTOCHEMISTRY REVIEWS
- Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways
- (2015) Valerie B. Sampson et al. PLoS One
- Dual-acting histone deacetylase-topoisomerase I inhibitors
- (2013) William Guerrant et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents
- (2013) Raffaella Cincinelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
- (2013) Sharad Ghamande et al. INVESTIGATIONAL NEW DRUGS
- Drugging Topoisomerases: Lessons and Challenges
- (2012) Yves Pommier ACS Chemical Biology
- Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
- (2012) Jhanelle Gray et al. CANCER BIOLOGY & THERAPY
- Preclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma
- (2011) Pamela N Munster et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecan
- (2011) Marije Slingerland et al. INVESTIGATIONAL NEW DRUGS
- Antitumor Effect of Suberoylanilide Hydroxamic Acid and Topotecan in Renal Cancer Cells
- (2011) Akinori Sato et al. ONCOLOGY RESEARCH
- Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines
- (2010) Bhaswati Sarcar et al. JOURNAL OF NEURO-ONCOLOGY
- Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
- (2009) F. Bruzzese et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started